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Vitamin D and LL-37 in children with pneumonia  
 
INTRODUCTION 
Until recently, many health care professionals 
believed that the major health problems resulting 
from vitamin D insufficiency were limited to bone 
health, including rickets, osteomalacia, and 
osteoporosis. Recent studies suggest that vitamin D 
may have other actions outside of its classic 
functions related to bone and calcium homeostasis1. 
Vitamin D is involved in the regulation of 1000 
human genes2. Because few foods contain vitamin 
D, sunlight exposure is the primary determinant of 
vitamin D status in humans3.Vitamin D synthesis is 
initiated in the skin by UVB radiation from the sun 
activating its precursor 7-dehydrocholesterol, which 
then circulates in the blood to the liver, where it is 
converted into its main metabolite 25- 
hydroxyvitamin D '25(OH)D' which has blood level 
about 1000 times higher than the active metabolite, 
1,25-dihydroxy-vitamin D (1,25(OH)2D)4. 
It was thought that the conversion to 1, 25-
(OH)2D occurred only in the kidneys, but increasing 
evidence indicate that the cells of most organs have 
vitamin D receptor and, along with this, the 
capacity to synthesize 1, 25(OH)2D locally. This 
autocrine and paracrine synthesis of 1, 25(OH)2 D 
is dependent on serum 25(OH)D levels, the primary 
circulating form of vitamin D1. 
Until recently, serum 25(OH)D levels of at least 
25-50 nmol/L appeared to be adequate, based on the 
absence of rickets and improved skeletal outcomes, 
but increasing evidence suggests that the levels of 
at least 75 nmol/L are required for good health5. 
Emerging evidence indicate that vitamin D-
mediated innate immunity, particularly through 
enhanced expression of the human cathelicidin 
antimicrobial peptide (hCAP-18) is important in 
host defenses against respiratory tract pathogens6,7. 
Vitamin D insufficiency is widespread and is 
associated with increased incidence of respiratory 
tract infections in preliminary studies8,9. Cells of the 
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innate and adaptive immune system including 
macrophages, lymphocytes and dendritic cells 
express the vitamin D receptor (VDR) and respond 
to stimulation by1,25(OH)2D10. 
Cathelicidin, known as LL-37; which is cleaved 
from its precursor hCAP18 is an endogenous 
antimicrobial peptide active against a broad 
spectrum of infectious agents including gram 
negative and positive bacteria, fungi, mycobacteria 
and viruses by acting as chemoattractant for 
neutrophils and monocytes, and has a defined 
vitamin D-dependent mechanism10,11. 
LL-37 is highly expressed at barrier sites 
including respiratory and colonic epithelium, saliva, 
and skin and thus provides an important first line 
defense mechanism for the innate immune system 
to respond to infectious insults7. The addition of 
25(OH)D to the media up-regulated production of 
LL-37 suggesting that vitamin D has an important 
role in the production of anti-microbial peptides 
important for innate immunity7. 
Acute lower respiratory infection, primarily 
pneumonia, is a common cause of morbidity and 
mortality in children younger than 5 years of age, 
particularly in developing countries12. 
Clinical vitamin D deficiency (rickets) was 
associated with 13-fold increased risk of pneumonia 
in Ethiopian children less than 5 y of age13. 
However, we are unaware of studies that have 
investigated the role of subclinical vitamin D 
deficiency in respiratory tract infections among 
infants and young children in developing countries. 
As subclinical vitamin D deficiency is common 
even in countries with plentiful sunshine, this work 
aimed to evaluate the association between vitamin 




This case control study included 40 children (22 
males and 18 females) with proven diagnosis of 
pneumonia (7 had viral pneumonia with 
lymphocytosis and negative CRP and 33 had 
bacterial pneumonia with neutrophilia and positive 
CRP) of ages ranging from 2 to 5 years (X±SD: 
3.35± 0.9 years) who were admitted to chest unit of 
Pediatric Department, Zagazig University Hospital 
during the year 2009 through 2010.  
Exclusion criteria 
- Children under the age of 2 years. 
- Recurrent pneumonia, defined as two episodes or 
more in one year or more than three episodes of 
pneumonia in a child at any time, with 
radiographic clearing between episodes 14. 
- Infants with clinically diagnosed vitamin D 
deficiency rickets. 
- Children who needed ventilator or died from 
pneumonia. 
All patients were given IV ampicillin-sulbactam (in 
a dose of 150 mg/kg) divided every 12 hours and 
IV cefotaxime (in a dose of 100mg/kg) in 2 divided 
doses. Typically patients with uncomplicated 
community-acquired bacterial pneumonia respond 
to therapy with improvement in clinical symptoms 
(fever, cough, tachypnea, chest pain) within 48-96 
hours of initiation of antibiotics. Radiographic 
evidence of improvement substantially lags behind 
clinical improvement. A number of factors must be 
considered when a patient does not improve on 
appropriate antibiotic therapy (slowly resolving 
pneumonia)15. 
Forty healthy children (20 males and 20 females) of 
mean ages 3.4± 1.1 years were studied as control 
group. 
Ethical approval was obtained from the local 
research ethics committee and parents of all 
children gave an informed written consent prior to 
the study.  
All children were subjected to the following: 
1- History taking including socio-economic level, 
residence, sun exposure and history of  upper 
respiratory tract infection  
2- Clinical examination including body 
temperature, respiratory rate, cyanosis and local 
chest examination. 
3- Routine laboratory investigations including 
complete blood count (CBC), C-reactive protein 
(CRP)16 (positive above 6 mg/L) and erythrocyte 
sedimentation rate (ESR). 
4- Chest X ray (for patients only). 
5- Measurement of serum 25OHD: Two ml of 
venous blood were obtained centrifuged and 
serum was separated and stored at -20ºC until 
assayed. Serum level of 25OHD was measured 
after extraction using the immunodiagnostic 
enzyme immuno-assay (EIA) developed by 
Immuno-diagnostic, Bensheim and Biomedica, 
Wien Australia17. Catalog number 02082005 25 
OH vit D6.DOC. The cut off level of vitamin D 
was 35 nmol/l.  
6- Measurement of human plasma LL-37: Tow ml 
venous blood sample was collected on EDTA, 
centrifuged and plasma was separated. The 
plasma stored at -70ºC in polypropylene tubes 
until assay. The human LL-37 was measured 
using solid-phase enzyme linked immunosorbent 
assay (ELISA) based on the sandwich principle 
using a commercial human LL-37 ELISA kit, 
HK321 Hycult Biotech, Fronststraat 2a, 5405PB 
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Uden, the Netherlands18. The cut off level of LL 
37 was 20 ng/ml.   
 
Statistical analysis 
Data were presented as mean ± standard deviation 
(X±SD) or percentage (%). The means of two 
groups were compared using student "t" test. Linear 
correlation and regression were used to test the 
correlation between the measured parameters. Odds 
ratio was used to quantify the risk. Cut of values 
were calculated from the ROC curve as mean ± 
2SD of control. Data were tabulated and 
statistically analyzed with the statistical package for 
Social Sciences (SPPS) version 14 software. P-
values less than 0.05 were considered significant19. 
   
RESULTS 
Analysis of demographic characteristics of the 
studied groups revealed that there were 
nonsignificant differences between patients and 
controls as regard age, sex, socioeconomic state and 
residence (Table 1). 
Table 2 shows the laboratory data of 40 
children with pneumonia versus 40 control children. 
WBCs, ESR and CRP were significantly higher in 
patients than controls while hemoglobin levels were 
significantly lower. 
Absence of history of sun exposure, high 
WBCs counts and low levels of both 25OHD and 
LL-37 were considered risk factors for pneumonia 
while site of residence, hemoglobin level and 
platelet counts did not (Table 3).  
Table 4 shows that both vitamin D and LL-37 
were significantly lower in children with 
pneumonia than in control group.  
This study showed nonsignificant differences 
between children with resolved and those with 
slowly resolved pneumonia regarding vitamin D 
and LL-37 (Table 5). 
Our study showed a highly significant positive 
correlation between vitamin D and LL-37 in 
patients, control and in children with resolved 
pneumonia and a significant positive correlation in 
children with slowly resolved pneumonia (Table 6). 
 
 
Table 1: Demographic characteristics of the studied groups 




Variables     
0.82 - 0.21 3.4±1.1 3.35±0.9 Age (years) X±SD 
0.62 0.2 - 
 
20        50.0 
20        50.0 
 
22             55.5 
18             45.0 
Sex (n, %)    
  Male 
  Female       
0.067 3.33 - 
 
20        50.0 
20        50.0 
 
28             70.0 
12             30.0 
Socioeconomic level (n, %) 
    Low 
    Middle 
0.81 0.05 - 
 
14        35.0 
26        65.0 
 
15             37.5 
25             62.5 
Residence (n, %) 
  Urban 
   Rural         













<0.001 13.2 7.85±1.6 (5.7- 10.3) 15.76±3.4 (10.2 – 31.9) WBCs  (×103/mm3)   
<0.001 5.23 12.4±1.3 (10 -15) 11.2±0.7 (10 -12.7) Hemoglobin  (g/dL) 
0.67 0.98 217.4±22.3 (183 – 256) 221.9±17.9 (191- 260) Platelets count (×109/L)  
<0.001 17.86 11.6±4.1 (6.0 – 19) 33.1±6.4 (20 – 45) ESR  (mm/hr) 
<0.001 χ2 =56.17 
 
0     (0.0) 
40    (100) 
 
33   (82.5) 




WBCs: white blood cells, ESR: erythrocyte sedimentation rate, CRP: C-reactive protein, p< 0.001: highly 
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Table 3: Odds ratio of the demographic and laboratory data between studied groups 
























































































LL-37(ng/ml)           
<20 
>20 
OR: odds ratio, CI: confidence interval, **: Highly significant, *: Nonsignificant 
 
Table 4: Vitamin D and LL-37 among the studied groups 








40 - 120 
 
37.6±21.1 







15 - 25 
 
14.7±6.2 
5 - 25 
LL-37    
X±SD 
Range 
   p< 0.001: highly significant 
 









0.09 1.68 48.6±33.1 (20-95) 34.87±16.6 (20-80) Vitamin D 
0.59 0.85 13±6.2 (5-20) 15.1±6.2 (5-25) LL-37 
   p >0.05: nonsignificant 
 
Table 6: Correlation between vitamin D and LL-37 in studied groups 
P          r  
<0.001 0.76 Control        
<0.001 0.6 Patients       
<0.001 0.72 Resolved pneumonia     
<0.05 0.66 Slowly resolved pneumonia  





In our series, patients had significantly lower 
25OHD levels than controls which can be explained 
by history of inadequate sun exposure in our 
patients.  
In this study, there were nonsignificant 
differences between patients and controls regarding 
age, socioeconomic state and site of residence to 
explain the low levels of 25OHD in the patient 
group and this is in agreement with an Indian study 
which revealed non significant differences between 
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cases of severe acute lower respiratory infections 
and controls in mean ages or distribution20. Similar 
results were also reported by other studies21.  
In our study, patients had significantly lower 
LL-37 levels than controls. The decrease in LL-37 
is the result of the decrease in 25OHD. LL37 is 
produced on epithelial surfaces and within 
circulating leukocytes that are capable of killing 
viruses, bacteria, and fungi22. Vitamin D (produced 
in response to sunlight) has recently been shown to 
have an important role in the innate   immune 
system. It stimulates the secretion of natural 
antibiotics known as antimicrobial peptides. These 
peptides include β-defensins and cathelicidins (LL-
37)23. It has been found that vitamin D has 
additional defensive roles such as regulating the 
inflammatory response and chemo-attracting cells 
of the adaptive immune system to wound or 
infection sites, binding and neutralizing lipopoly-
saccharides, and promoting re-epthelialization11,24. 
Ensuring optimal vitamin D levels -through 
appropriate sunlight exposure, diet, if necessary, 
supplementation- is likely to help ensure optimum 
protection from infectious diseases. This has 
particular relevance in the winter as vitamin D 
levels tend to bottom out. In fact, lower level of 
vitamin D may well be a factor in why it is that 
infectious diseases such as cold, flu and pneumonia 
tend to be more common in the winter25,26 .This 
gives vitamin D the potential to combat a range of 
infections. Bartley27 and Ginde et al.28 reported that 
vitamin D is involved in the production of defensins 
and cathelicidin which provide a natural defense 
against potential microbiological pathogens and 
concluded that vitamin D supplementation increases 
cathelicidin production. Also, Jeng et al.26  declared 
that plasma LL-37 levels were significantly lower 
in critically ill patients with and without sepsis 
compared to the healthy controls. 
In support of the role of 25OHD in the 
production of LL-37, the present study revealed a 
significant positive correlation between vitamin D 
and LL-37 in control children (r=0.76) and patients 
with resolved pneumonia (r=0.72), as well as in 
patients with slowly resolved pneumonia (r=0.66). 
A similar positive correlation was also found by 
Jeng et al.26. 
The finding of significantly higher WBCs, ESR 
and CRP and significantly lower hemoglobin levels 
in patients compared to controls is a well known 
response in patients with pneumonia as has been 
reported by other investigators15.  
In our study, positive previous history of sun 
exposure, normal WBC count, normal 25OH D 
level >35 nmol/L and normal LL-37 level >25 
ng/ml carry a significantly lower risk for 
development of pneumonia in children while site of 
residence, hemoglobin level and platelet count did 
not have any risk. Similar results were reported by 
Wayse et al.20 who declared that factors 
significantly associated with decreased risk of 
severe acute lower respiratory infection in 
univariate analysis were: infant not covered in 
swaddling clothes when exposed to sunlight before 
crawling and serum 25OHD3 >22.5 nmol/l . Also, a 
Finnish cohort study found that young male soldiers 
with serum 25OHD levels less than 40 nmol/l at 
baseline had a 63% increased risk of absence from 
duty due to respiratory infections over the following 
6 months than soldiers with levels ≥ 40 nmol/L8. 
Additionally a Turkish case control study found that 
serum 25OHD levels were lower in neonatal cases 
of acute lower respiratory infection (22.8 nmol/l) 
than in age-matched controls (40.8 nmol/l)28. In 
contrast to our result, a Canadian case control study 
of children 1 to 25 months old found no difference 
in mean serum 25OHD levels between patients with 
acute lower respiratory tract infection (77.0 nmol/l) 
and hospital controls (77.2 nmol/l), the average 
vitamin D status of these individuals was greater 
than 75 nmol/l, which can be explained by that all 
the studied infants consumed vitamin D through 
fortified infant formula or supplements25. 
In this study, we did not find any significant 
difference in the mean serum vitamin D and LL-37 
levels between patients with resolved and those 
with slowly resolved pneumonia. Slow resolution 
can be explained by  a number of other factors such 
as bacterial resistance, non bacterial etiologies such 
as viruses and aspiration of foreign body or food,  
mucous plugs and pre-existing diseases such as 
immunodeficiencies, ciliary dyskinesia, cystic 
fibrosis, pulmonary sequestration, or cystic 
adenomatoid malformation, that must be considered 
when a patient does not improve on appropriate 
antibiotic therapy15 .This result  can be explained by 
that  LL-37 plays a role in the defense against 
infection but once infection has taken place, other 
factors determine its course and whether it will 
resolve or not. 
In conclusion, inappropriate concentrations of 
vitamin D decrease the ability of the immune 
system to defend against respiratory infections 
through lowering LL-37. So, we recommend 
appropriate vitamin D supplementation and sun 
exposure to decrease the risk of respiratory tract 
infections and performing further studies to define 
the exact relation of vitamin D status to other 
infections. 
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